CLINICAL_TRIALS
trial_result
· 2023-07-18
Clinical Trial Update: Assessing PA-824 for Tuberculosis (the APT Trial) [Phase 2]
Summary
Phase 2 trial update for PA-824 ( pretomanid) in pulmonary tuberculosis; results completed with data posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Johns Hopkins University | Conditions: Pulmonary Tuberculosis | Phase 2 | Status: COMPLETED | Results posted: 2023-07-18